ライフサイエンスコーパス: Blastomyces

1 We investigated whether blastomyces adhesin 1 (BAD1) exploits host receptors for

2 BAD-1 (Blastomyces adhesin 1), a 120-kDa protein of Blastomyces

3 were not resolved and the nearest outgroups (Blastomyces and Paracoccidioides) were too distant to un

4 fungal pulmonary infections with two agents, Blastomyces dermatitidis an extracellular pathogen, and

5 D4(+) T cells respond to a native epitope in Blastomyces dermatitidis and also in Histoplasma capsula

6 at regulates dimorphism and pathogenicity in Blastomyces dermatitidis and H. capsulatum.

7 Blastomyces dermatitidis and Histoplasma capsulatum are

8 dhesin is indispensable for pathogenicity of Blastomyces dermatitidis and is thought to promote pulmo

9 g of the molecular bases of pathogenicity in Blastomyces dermatitidis and related systemic dimorphic

10 We report results of an immunoassay for Blastomyces dermatitidis antigenuria.

11 n real-time PCR assay was developed from the Blastomyces dermatitidis BAD1 gene promoter.

12 inically important discrepancy was observed (Blastomyces dermatitidis by culture and Cryptococcus neo

13 40/CD40L interactions in vaccine immunity to Blastomyces dermatitidis by immunizing CD40(-/-) and CD4

14 The dimorphic fungal pathogen Blastomyces dermatitidis can infect immunocompetent pati

15 cally engineered, live, attenuated strain of Blastomyces dermatitidis carrying a targeted deletion at

16 e (3-week-old) mice killed nonphagocytizable Blastomyces dermatitidis cells less (25%) than did cells

17 Recent studies showed that attenuated Blastomyces dermatitidis confers protection via T cell r

18 ast cytosol extract (YCE) crude antigen from Blastomyces dermatitidis confers T-cell-mediated resista

19 ld was found to be positive by the AccuProbe Blastomyces dermatitidis Culture ID Test (Gen-Probe Inc.

20 People infected with Blastomyces dermatitidis develop strong immunity to the

21 Humans infected with the dimorphic fungus Blastomyces dermatitidis develop strong T-lymphocyte res

22 African strains of Blastomyces dermatitidis differ from North American stra

23 We report that the pathogenic yeast of Blastomyces dermatitidis elaborates dipeptidyl-peptidase

24 Infection with Blastomyces dermatitidis elicits strong antibody respons

25 Pathogenic yeast of Blastomyces dermatitidis express a surface protein adhes

26 ccus neoformans, Histoplasma capsulatum, and Blastomyces dermatitidis from blood cultures.

27 genetically engineered attenuated strain of Blastomyces dermatitidis given s.c. as a vaccine, wherea

28 tools available for genetic manipulation of Blastomyces dermatitidis have enhanced our ability to st

29 vaccines to induce protection against lethal Blastomyces dermatitidis infection in mice and is far mo

30 -dependent mechanisms of vaccine immunity to Blastomyces dermatitidis infection.

31 ed immunity is pivotal in host resistance to Blastomyces dermatitidis infection.

32 Blastomyces dermatitidis is a primary fungal pathogen of

33 Blastomyces dermatitidis is a thermally induced dimorphi

34 ulmonary infection with the dimorphic fungus Blastomyces dermatitidis often progresses and requires t

35 The fungal pathogen Blastomyces dermatitidis produces an adhesin (WI-1) in y

36 R senses mannan on the surface of attenuated Blastomyces dermatitidis vaccine yeast and that MR(-/-)

37 found that serum inhibitory activity against Blastomyces dermatitidis was principally mediated by alb

38 Our previous studies showed that Blastomyces dermatitidis yeast activates the human compl

39 emory after vaccination with transgenic (Tg) Blastomyces dermatitidis yeasts that display a model Ag,

40 oides posadasii, Histoplasma capsulatum, and Blastomyces dermatitidis), have soared recently, spurrin

41 Blastomyces dermatitidis, a dimorphic fungus and the cau

42 f serum factors or MBL on the interaction of Blastomyces dermatitidis, a pulmonary fungal pathogen, w

43 gi Histoplasma capsulatum, Coccidioides spp, Blastomyces dermatitidis, and Paracoccidioides brasilien

44 role in phagocyte recognition and killing of Blastomyces dermatitidis, but little is known about how

45 igatus, Aspergillus terreus, Bipolaris spp., Blastomyces dermatitidis, Cladophialophora bantiana, Fus

46 to amplify DNA from Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Paracocc

47 , a virulence factor in the dimorphic fungus Blastomyces dermatitidis, for expression in yeast and my

48 Blastomyces adhesin 1), a 120-kDa protein of Blastomyces dermatitidis, functions as an adhesin, immun

49 Pseudallescheria boydii, Rhizopus arrhizus, Blastomyces dermatitidis, Histoplasma capsulatum, and Sp

50 BAD1, an adhesin and immune modulator of Blastomyces dermatitidis, is an essential virulence fact

51 BAD1, a virulence factor of Blastomyces dermatitidis, is displayed on yeast and rele

52 ved in specimens from patients infected with Blastomyces dermatitidis, Paracoccidioides brasiliensis,

53 Yeast forms of Blastomyces dermatitidis, Sporothrix schenckii, and Hist

54 In Blastomyces dermatitidis, the agent of blastomycosis, a

55 nsia crescens, an agent of adiaspiromycosis, Blastomyces dermatitidis, the agent of blastomycosis, an

56 Blastomyces dermatitidis, the etiologic agent of blastom

57 on caused by the soil-based dimorphic fungus Blastomyces dermatitidis, which is endemic throughout mu

58 ry delivery of an attenuated vaccine against Blastomyces dermatitidis.

59 e fluid (BALF) on the interaction of BAM and Blastomyces dermatitidis.

60 infection with Strongyloides stercoralis and Blastomyces dermatitidis.

61 from Candida glabrata, Candida albicans, and Blastomyces dermatitidis.

62 Certain elements resembled budding cells of Blastomyces dermatitidis.

63 t are shared with Histoplasma capsulatum and Blastomyces dermatitidis.

64 L in vaccine immunity to the fungal pathogen Blastomyces dermatitidis.

65 al report of hard-palate infection caused by Blastomyces dermatitidis.

66 antigen yielded no detectable reaction with Blastomyces of Histoplasma antiserum by ID.

67 Repeat testing with the Blastomyces probe demonstrated false-positive results wi

68 Using naive Blastomyces-specific transgenic CD4(+) T cells, we found

69 s spp. (n = 9), Histoplasma spp. (n = 7) and Blastomyces spp. (n = 3).

70 Blastomyces spp. antigen testing was evaluated over a 10

71 BYS1 (Blastomyces yeast-phase-specific 1), first identified by